Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Applying perceptual and adaptive learning techniques for teaching introductory histopathology.

Krasne S, Hillman JD, Kellman PJ, Drake TA.

J Pathol Inform. 2013 Dec 31;4:34. doi: 10.4103/2153-3539.123991. eCollection 2013.

2.

A biopsy was performed of a verrucous papule on the plantar surface of the left foot in a 25-year-old man. The best diagnosis is: Myrmecia.

Elkeeb L, Spicknall KE, Hillman JD.

Cutis. 2013 May;91(5):229, 235-6. No abstract available.

PMID:
23772436
3.

Site-directed mutations in the lanthipeptide mutacin 1140.

Chen S, Wilson-Stanford S, Cromwell W, Hillman JD, Guerrero A, Allen CA, Sorg JA, Smith L.

Appl Environ Microbiol. 2013 Jul;79(13):4015-23. doi: 10.1128/AEM.00704-13. Epub 2013 Apr 19.

4.

Acral lymphomatoid papulosis associated with poikilodermatous mycosis fungoides.

Magorien J, Hillman JD, Pinter-Brown LC, Said J, Chiu MW.

Dermatol Online J. 2013 Feb 15;19(2):1.

PMID:
23473271
5.

Bilateral thick crusts on the legs.

Richter LL, Miller RM, Hillman JD, Chiu MW.

Int J Dermatol. 2013 Feb;52(2):133-5. doi: 10.1111/j.1365-4632.2012.05678.x. No abstract available.

PMID:
23347299
6.

Genetic profiling of BRAF inhibitor-induced keratoacanthomas reveals no induction of MAP kinase pathway expression.

Kulkarni RP, Plaisier S, Ra SH, Li X, Lee DJ, Hillman JD, Binder SW.

J Invest Dermatol. 2013 Mar;133(3):830-833. doi: 10.1038/jid.2012.353. Epub 2012 Sep 27. No abstract available.

7.

Identification of genes expressed in cultures of E. coli lysogens carrying the Shiga toxin-encoding prophage Φ24B.

Riley LM, Veses-Garcia M, Hillman JD, Handfield M, McCarthy AJ, Allison HE.

BMC Microbiol. 2012 Mar 22;12:42. doi: 10.1186/1471-2180-12-42.

8.

A case of verrucous psoriasis.

Monroe HR, Hillman JD, Chiu MW.

Dermatol Online J. 2011 May 15;17(5):10. Review.

9.

Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140.

Ghobrial O, Derendorf H, Hillman JD.

Eur J Pharm Sci. 2010 Dec 23;41(5):658-64. doi: 10.1016/j.ejps.2010.09.005. Epub 2010 Sep 30.

PMID:
20869439
10.

Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease.

Mitter SS, Derhovanessian A, Hillman JD, Uslan DZ.

Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):231-5. doi: 10.1038/nrgastro.2010.20.

PMID:
20376095
11.

Pharmacokinetic and pharmacodynamic evaluation of the lantibiotic MU1140.

Ghobrial O, Derendorf H, Hillman JD.

J Pharm Sci. 2010 May;99(5):2521-8. doi: 10.1002/jps.22015.

PMID:
20039385
12.

Safety assessment of ProBiora3, a probiotic mouthwash: subchronic toxicity study in rats.

Hillman JD, McDonell E, Hillman CH, Zahradnik RT, Soni MG.

Int J Toxicol. 2009 Sep-Oct;28(5):357-67. doi: 10.1177/1091581809340705.

PMID:
19815843
13.

Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.

Murali R, Cochran AJ, Cook MG, Hillman JD, Karim RZ, Moncrieff M, Starz H, Thompson JF, Scolyer RA.

Cancer. 2009 Nov 1;115(21):5026-37. doi: 10.1002/cncr.24298.

14.

Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash.

Zahradnik RT, Magnusson I, Walker C, McDonell E, Hillman CH, Hillman JD.

J Appl Microbiol. 2009 Aug;107(2):682-90. doi: 10.1111/j.1365-2672.2009.04243.x. Epub 2009 Mar 30.

15.

A spontaneous lactate dehydrogenase deficient mutant of Streptococcus rattus for use as a probiotic in the prevention of dental caries.

Hillman JD, McDonell E, Cramm T, Hillman CH, Zahradnik RT.

J Appl Microbiol. 2009 Nov;107(5):1551-8. doi: 10.1111/j.1365-2672.2009.04333.x. Epub 2009 Apr 24.

16.

Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma.

Ghobrial OG, Derendorf H, Hillman JD.

J Pharm Biomed Anal. 2009 May 1;49(4):970-5. doi: 10.1016/j.jpba.2008.12.022. Epub 2008 Dec 24.

PMID:
19269770
17.

Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.

Smith L, Hillman J.

Curr Opin Microbiol. 2008 Oct;11(5):401-8. doi: 10.1016/j.mib.2008.09.008. Epub 2008 Oct 24. Review.

18.

Pharmacodynamic activity of the lantibiotic MU1140.

Ghobrial OG, Derendorf H, Hillman JD.

Int J Antimicrob Agents. 2009 Jan;33(1):70-4. doi: 10.1016/j.ijantimicag.2008.07.028. Epub 2008 Oct 2.

19.

Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis.

Rollins SM, Peppercorn A, Young JS, Drysdale M, Baresch A, Bikowski MV, Ashford DA, Quinn CP, Handfield M, Hillman JD, Lyons CR, Koehler TM, Calderwood SB, Ryan ET.

PLoS One. 2008 Mar 19;3(3):e1824. doi: 10.1371/journal.pone.0001824.

20.

Elucidation of the antimicrobial mechanism of mutacin 1140.

Smith L, Hasper H, Breukink E, Novak J, Cerkasov J, Hillman JD, Wilson-Stanford S, Orugunty RS.

Biochemistry. 2008 Mar 11;47(10):3308-14. doi: 10.1021/bi701262z. Epub 2008 Feb 12.

PMID:
18266322
21.

Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials.

Hillman JD, Mo J, McDonell E, Cvitkovitch D, Hillman CH.

J Appl Microbiol. 2007 May;102(5):1209-19. Review.

22.

Histopathologic findings of disseminated coccidioidomycosis with hyphae.

Kappel ST, Wu JJ, Hillman JD, Linden KG.

Arch Dermatol. 2007 Apr;143(4):548-9. No abstract available.

PMID:
17438198
23.

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, de Kruijff B, Breukink E.

Science. 2006 Sep 15;313(5793):1636-7.

24.

Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi.

Harris JB, Baresch-Bernal A, Rollins SM, Alam A, LaRocque RC, Bikowski M, Peppercorn AF, Handfield M, Hillman JD, Qadri F, Calderwood SB, Hohmann E, Breiman RF, Brooks WA, Ryan ET.

Infect Immun. 2006 Sep;74(9):5161-8.

25.

In vivo induced antigen technology (IVIAT) and change mediated antigen technology (CMAT).

Handfield M, Hillman JD.

Infect Disord Drug Targets. 2006 Sep;6(3):327-34. Review.

PMID:
16918490
26.

Identification of group A Streptococcus antigenic determinants upregulated in vivo.

Salim KY, Cvitkovitch DG, Chang P, Bast DJ, Handfield M, Hillman JD, de Azavedo JC.

Infect Immun. 2005 Sep;73(9):6026-38.

27.

Genes of periodontopathogens expressed during human disease.

Song YH, Kozarov EV, Walters SM, Cao SL, Handfield M, Hillman JD, Progulske-Fox A.

Ann Periodontol. 2002 Dec;7(1):38-42.

PMID:
16013215
28.

Microarray analysis of quorum-sensing-regulated genes in Porphyromonas gingivalis.

Yuan L, Hillman JD, Progulske-Fox A.

Infect Immun. 2005 Jul;73(7):4146-54.

29.

In vivo induced genes in human diseases.

Handfield M, Progulske-Fox A, Hillman JD.

Periodontol 2000. 2005;38:123-34. No abstract available.

PMID:
15853939
30.

Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.

John M, Kudva IT, Griffin RW, Dodson AW, McManus B, Krastins B, Sarracino D, Progulske-Fox A, Hillman JD, Handfield M, Tarr PI, Calderwood SB.

Infect Immun. 2005 May;73(5):2665-79.

31.

In vivo induced antigen technology (IVIAT).

Rollins SM, Peppercorn A, Hang L, Hillman JD, Calderwood SB, Handfield M, Ryan ET.

Cell Microbiol. 2005 Jan;7(1):1-9. Review.

PMID:
15617518
32.

In vivo induced antigenic determinants of Actinobacillus actinomycetemcomitans.

Cao SL, Progulske-Fox A, Hillman JD, Handfield M.

FEMS Microbiol Lett. 2004 Aug 1;237(1):97-103.

33.

Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients.

Kim YR, Lee SE, Kim CM, Kim SY, Shin EK, Shin DH, Chung SS, Choy HE, Progulske-Fox A, Hillman JD, Handfield M, Rhee JH.

Infect Immun. 2003 Oct;71(10):5461-71.

34.

Structure and dynamics of the lantibiotic mutacin 1140.

Smith L, Zachariah C, Thirumoorthy R, Rocca J, Novák J, Hillman JD, Edison AS.

Biochemistry. 2003 Sep 9;42(35):10372-84.

PMID:
12950164
35.

Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae.

Hang L, John M, Asaduzzaman M, Bridges EA, Vanderspurt C, Kirn TJ, Taylor RK, Hillman JD, Progulske-Fox A, Handfield M, Ryan ET, Calderwood SB.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8508-13. Epub 2003 Jun 25.

36.

Identification of Candida albicans genes induced during thrush offers insight into pathogenesis.

Cheng S, Clancy CJ, Checkley MA, Handfield M, Hillman JD, Progulske-Fox A, Lewin AS, Fidel PL, Nguyen MH.

Mol Microbiol. 2003 Jun;48(5):1275-88.

37.

In vivo expression of bacterial genes during human infections.

Handfield M, Seifert T, Hillman JD.

Methods Mol Med. 2003;71:225-42. Review. No abstract available.

PMID:
12374023
38.

Genetically modified Streptococcus mutans for the prevention of dental caries.

Hillman JD.

Antonie Van Leeuwenhoek. 2002 Aug;82(1-4):361-6. Review.

PMID:
12369203
39.

Identification and testing of Porphyromonas gingivalis virulence genes with a pPGIVET system.

Wu Y, Lee SW, Hillman JD, Progulske-Fox A.

Infect Immun. 2002 Feb;70(2):928-37.

40.
41.

Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics.

Smith L, Novák J, Rocca J, McClung S, Hillman JD, Edison AS.

Eur J Biochem. 2000 Dec;267(23):6810-6.

42.

IVIAT: a novel method to identify microbial genes expressed specifically during human infections.

Handfield M, Brady LJ, Progulske-Fox A, Hillman JD.

Trends Microbiol. 2000 Jul;8(7):336-9. Review.

PMID:
10878769
43.

Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries.

Hillman JD, Brooks TA, Michalek SM, Harmon CC, Snoep JL, van Der Weijden CC.

Infect Immun. 2000 Feb;68(2):543-9.

44.

Tn917-lac mutagenesis of Streptococcus mutans to identify environmentally regulated genes.

Cvitkovitch DG, Gutierrez JA, Behari J, Youngman PJ, Wetz JE, Crowley PJ, Hillman JD, Brady LJ, Bleiweis AS.

FEMS Microbiol Lett. 2000 Jan 1;182(1):149-54.

45.

Streptococcus mutans ffh, a gene encoding a homologue of the 54 kDa subunit of the signal recognition particle, is involved in resistance to acid stress.

Gutierrez JA, Crowley PJ, Cvitkovitch DG, Brady LJ, Hamilton IR, Hillman JD, Bleiweis AS.

Microbiology. 1999 Feb;145 ( Pt 2):357-66.

PMID:
10075418
46.

Genetic and biochemical analysis of mutacin 1140, a lantibiotic from Streptococcus mutans.

Hillman JD, Novák J, Sagura E, Gutierrez JA, Brooks TA, Crowley PJ, Hess M, Azizi A, Leung K, Cvitkovitch D, Bleiweis AS.

Infect Immun. 1998 Jun;66(6):2743-9.

47.

Cloning and characterization of a Prevotella melaninogenica hemolysin.

Allison HE, Hillman JD.

Infect Immun. 1997 Jul;65(7):2765-71.

48.

Genetic and physiologic analysis of a formyl-tetrahydrofolate synthetase mutant of Streptococcus mutans.

Crowley PJ, Gutierrez JA, Hillman JD, Bleiweis AS.

J Bacteriol. 1997 Mar;179(5):1563-72.

49.

Supplemental Content

Loading ...
Support Center